宫颈癌分期的历史回顾、面临的问题与未来发展  

History, problem and prospect of cervical cancer FIGO staging system

作　　者：王彤[1] 吴玉梅[1] 

机构地区：[1]首都医科大学附属北京妇产医院妇科肿瘤科,北京100006

出　　处：《中国医药导报》2017年第24期46-49,共4页China Medical Herald

基　　金：北京市医院管理局临床医学发展专项经费资助项目(ZYLX201705)

摘　　要：宫颈癌是唯一一个目前还在使用临床分期的妇科恶性肿瘤,通过对宫颈癌分期制订过程的历史回顾,可以了解其一直存在的问题。对宫颈癌尝试手术病理分期的探索研究尤其是治疗前淋巴结状态的评价纳入分期体系是宫颈癌临床研究的热点及难点。治疗前淋巴结状态评价的方法包括更精确的影像学检查方法如PET-CT、MRI、CT等检查判断是否有转移,腹腔镜/开腹/Robert机器人的腹膜内/腹膜外盆腔淋巴结和腹主动脉旁淋巴结切除或活检,是目前研究的热点,为宫颈癌分期提供了新的更精确的方法。Cervical cancer staging-system is the first designed staging system for gynecological cancer and the only system has not been changed to surgical-pathological system. Through reviewing the designed history of cervical cancer can understand the persistent problems of the clinical staging system. Recently exploration of surgical-pathological system for cervical cancer is hot point. More accuracy imaging examination methods such as PET-CT, MRI, CT are used to detect metastatic lymph nodes in patients with cervical cancer, specially surgical pelvic and paraaortic lymphadenectomy or lymph nodes biopsy（including laparotomy, abdominal and Robotic-Assisted） being applied in cervical cancer surgical-pathologic staging and scoring system explore a new and accuracy assessment way.

关 键 词：宫颈癌 分期 手术病理分期 准确性 预后 

分 类 号：R737.33[医药卫生—肿瘤]